Status:
COMPLETED
STD Risk Reduction for Heterosexual Methamphetamine Users
Lead Sponsor:
University of California, San Diego
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Substance-Related Disorders
HIV Infections
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will evaluate the effectiveness of a sexual risk reduction intervention in reducing sexual risk behavior in HIV uninfected, heterosexual people who use methamphetamine.
Detailed Description
Methamphetamine is an addictive stimulant drug that strongly activates certain systems in the brain and can cause strong feelings of euphoria. Methamphetamine use has been associated with high risk se...
Eligibility Criteria
Inclusion
- HIV uninfected
- Use of methamphetamine via snorting or smoking at least once a month for the 2 months prior to study entry
- Heterosexual
- History of unprotected sex within 2 months prior to study entry
Exclusion
- Current diagnosis of a major psychiatric disorder with psychotic or suicidal symptoms
- History of consistent use of condoms or dental dams for oral, vaginal, or anal sex with all partners within 2 months prior to study entry
- Currently trying to get pregnant or get a partner pregnant
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2012
Estimated Enrollment :
432 Patients enrolled
Trial Details
Trial ID
NCT00344214
Start Date
October 1 2006
End Date
August 1 2012
Last Update
September 28 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HIV Neurobehavioral Research Center
San Diego, California, United States, 92103